Stock INTEG B INTEGRUM AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Integrum AB

Equities

INTEG B

SE0009807266

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:44 2024-04-16 am EDT 		5-day change 1st Jan Change
59 SEK -1.01% Intraday chart for Integrum AB +15.69% +29.24%
Mar. 26 Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel CI
Feb. 29 Integrum AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Integrum: Anchoring its position as niche leader
AQ
Integrum expands its product offering into the Israeli market
AQ
Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel
CI
Health economic study shows positive outcome using Integrum's OPRA[TM] Implant System over socket prostheses in transfemoral amputees
AQ
Integrum Q3 - In line and no estimate changes
AQ
A new record revenue quarter with 61% growth
AQ
Integrum AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
CI
Integrum AB, Invitation to the Third Quarter 2023, 24 Results Presentation
AQ
Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation
AQ
Integrum has sold and delivered OPRA[TM] Implant Systems to a value of SEK 3.5 million to Center of Excellence in Ukraine
AQ
Integrum Sells and Delivers Opratm Implant Systems to A Value of SEK 3.5 Million to Center of Excellence in Ukraine
CI
Integrum establishes Center of Excellence in Ukraine
AQ
Integrum AB Establishes Center of Excellence in Ukraine
CI
Integrum's MDR certification is completed for the OPRA[TM] Implant System
AQ
Integrum Q2 - Alive and kicking
AQ
Record sales and profitability
AQ
Integrum AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
CI
Integrum AB changes Certified Adviser to Carnegie Investment Bank AB (publ)
AQ
Integrum AB: Invitation to the Second Quarter 2023/24 Results Presentation
AQ
Integrum plans to submit a PMA application to the FDA for the use of OPRA in transhumeral amputations based on existing clinical data
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INTEG B Stock
  4. News Integrum AB